U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07579156) titled 'TearCare in Young Adults' on May 04.
Brief Summary: This study is a non-randomized, open-label, interventional trial of TearCare(R) eyelid warming and manual meibomian gland expression in young adults with clinically significant meibomian gland dysfunction (MGD). Intervention is with TearCare(R) performed at Visit 1. A single follow-up examination occurs at Day 28.
Study Start Date: Aug. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Meibomian Gland Dysfunction (Disorder)
Intervention:
DEVICE: TearCare(R)
The TearCare system is designed to deliver controlled, precise heat to the tarsal plates and underlying MGs of the eyelids ...